As of Jan 13
| 0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Aevi Genomic Medicine Inc have a median target of 13.00, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +155.91% increase from the last price of 5.08.
The current consensus among 5 polled investment analysts is to Buy stock in Aevi Genomic Medicine Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.